One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...

These 10 stocks could mint the next wave of millionaires › Turning Point Brands (NYSE:TPB), the consumer products company known for its iconic tobacco and cannabis accessories brands, released its ...

A year ago, applications for a cell-cultured foie gras product were dropped off at the United States Food and Drug ...

Q2 2025 Management View CEO David L. Hallal emphasized Scholar Rock is “scaling for the next phase of growth as a commercial stage fully integrated global biopharmaceutical company.” He outlined three ...

Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in ...

GAAP EPS loss widened to $(1.22) from $(1.10) year over year in Q2 2025 as R&D expenses rose 47.7% and G&A expenses climbed 48.8% compared to Q2 2024. VAX-31 vaccine program advanced with FDA expanded ...

Q2 2025 Management View CEO Adam S. Grossman opened by stating that "ADMA's second quarter 2025 performance underscores the strength of our operating model, the success of our strategic execution and ...

As of fiscal year-end 2025, McKesson held cash and cash equivalents of $5.7 billion with outstanding debt at $4.4 billion. Roughly one third of its debt is due to mature over the next three years, and ...

Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its ...

Oral ciprofloxacin alone was as effective as a regimen combined with an injectable antibiotic for bubonic plague, a ...

Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP ...